Equities

Streamline Health Solutions Inc

Streamline Health Solutions Inc

Actions
TechnologyTechnology
  • Price (USD)2.97
  • Today's Change-0.05 / -1.66%
  • Shares traded6.61k
  • 1 Year change-29.56%
  • Beta1.6959
Data delayed at least 15 minutes, as of Nov 22 2024 17:57 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Streamline Health Solutions, Inc. enables healthcare organizations to proactively address revenue leakage and improve financial performance. The Company delivers integrated solutions, technology-enabled services and analytics. It operates in one segment as a provider of health information technology solutions and associated services that improve healthcare processes and information flows within a healthcare facility. The Company sells its solutions and services in North America to hospitals and health systems through its direct sales force and its reseller partnerships. It offers solutions and services to assist its clients in revenue cycle management, including its two flagship technologies: RevIDTM and eValuatorTM. RevID offers automated, daily reconciliation of clinical event activity to patient billing charge items prior to billing. eValuator provides 100% automated coding analysis prior to billing. It offers an array of professional services, including system implementation.

  • Revenue in USD (TTM)20.30m
  • Net income in USD-18.82m
  • Incorporated1996
  • Employees77.00
  • Location
    Streamline Health Solutions Inc2400 Old Milton Parkway, Box 1353ALPHARETTA 30009United StatesUSA
  • Phone+1 (404) 446-2051
  • Fax+1 (302) 674-5266
  • Websitehttps://www.streamlinehealth.net/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
ATI Physical Therapy Inc741.86m-79.62m6.66m6.00k------0.009-18.57-18.57174.1717.200.7625--8.02123,643.80-5.49---6.39--16.13---7.21----0.19050.8762--9.97--73.20------
Inspire Veterinary Partners Inc17.13m-19.33m7.10m156.00------0.4146-134.72-134.724.54-0.6310.816521.61246.52109,778.20-89.79---190.96--19.47---109.98--0.1311-2.741.20--69.56---206.68------
Ontrak Inc11.24m-35.68m7.72m102.00--0.5432--0.6868-10.55-10.553.023.370.5207--21.66110,186.30-123.82-54.80-228.86-73.3764.0053.50-237.77-71.95---2.270.4088---12.20-3.4439.08--99.58--
Univec Inc-100.00bn-100.00bn7.95m3.00---------------0.0113-----------50.96------17.47---198.310.0051-------74.07-64.8336.83------
Healthlynked Corp3.32m-6.19m9.14m38.00------2.75-0.0222-0.02220.0119-0.00690.786215.8281.3287,385.27-146.48-119.37-966.37-332.2247.3355.81-186.32-119.260.4586-4.69-----2.3220.4357.08---12.94--
Xcelerate Inc3.96m-296.19k9.90m1.00--7.12--2.50-0.0014-0.00140.01890.00321.516.133.90---11.334.24-49.19--71.7174.10-7.481.930.4797-0.82180.7237--6.6310.4317.00--174.06--
Pacific Health Care Organization Inc6.17m869.09k10.50m30.0012.090.921411.591.700.06780.06780.48120.890.5259--6.40205,557.707.417.297.937.8179.0382.7514.0913.28----0.00---2.00-3.7055.80-10.80-15.93--
Oncology Institute Inc378.93m-57.46m11.70m800.00--0.7565--0.0309-0.7706-0.77065.080.20491.9129.197.36473,666.30-35.34---44.12--14.1819.54-18.53-9.992.27-7.440.8553--28.4223.43-99,919.12--45.68--
Interpace Biosciences Inc44.89m4.89m11.80m108.002.43--2.290.2631.101.0610.13-2.533.1715.357.41415,675.9034.54-38.19---69.7360.4649.4410.88-41.010.52698.11----26.3112.93118.96--0.9184--
Aesthetic Medical Intl Hldg Grp Ltd(ADR)100.41m-6.69m11.96m1.29k--3.116.040.1191-0.1485-0.14852.210.08061.2920.8277.3678,081.45-9.06-23.36-35.45-48.5845.3955.32-7.02-23.720.2031-5.500.9581--1.86-2.1650.91--3.70--
Streamline Health Solutions Inc20.30m-18.82m12.75m77.00--12.03--0.628-0.3277-0.32770.34990.25110.4397--7.64263,636.40-40.77-22.06-56.63-31.6950.8649.96-92.72-54.55---4.460.4395---9.210.2057-64.31---11.72--
Psychemedics Corp.20.26m-3.00m13.79m116.00--2.53--0.6809-0.5142-0.51423.470.92381.69--5.12174,637.90-25.02-7.44-40.58-9.7038.3637.55-14.78-6.26---292.900.0969---12.45-12.33-283.21---33.32--
PharmChem Inc6.00m1.27m14.64m170.0011.554.7311.532.440.27270.27271.290.66611.677.238.04--35.37--44.59--64.09--21.17--4.45--0.00--3.50---16.95------
ProPhase Labs Inc12.75m-27.76m18.55m113.00--0.3888--1.45-1.50-1.500.68872.000.1393.740.3629112,858.40-30.250.9106-40.111.12-32.3850.32-217.640.93251.33-12.780.2837665.78-63.8127.59-190.90--86.46--
Data as of Nov 22 2024. Currency figures normalised to Streamline Health Solutions Inc's reporting currency: US Dollar USD

Institutional shareholders

24.76%Per cent of shares held by top holders
HolderShares% Held
Tamarack Advisers LPas of 09 Aug 2024328.73k7.79%
Harbert Fund Advisors, Inc.as of 30 Sep 2024321.62k7.62%
Perkins Capital Management, Inc.as of 30 Sep 2024128.87k3.05%
The Vanguard Group, Inc.as of 30 Sep 2024110.57k2.62%
Nicholas Hoffman & Co. LLCas of 30 Sep 202448.14k1.14%
Geode Capital Management LLCas of 30 Sep 202433.52k0.79%
BlackRock Fund Advisorsas of 30 Sep 202421.17k0.50%
Cerity Partners LLCas of 30 Sep 202419.33k0.46%
Salem Investment Counselors, Inc.as of 30 Sep 202418.18k0.43%
Renaissance Technologies LLCas of 30 Sep 202415.17k0.36%
More ▼
Data from 09 Aug 2024 - 30 Sep 2024Source: FactSet Research Systems Inc.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.